Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More Potential
Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.
Diabetes or diet? Ozempic’s double life as a weight-loss miracle
Can this diabetes-control breakthrough also become the answer to obesity? From Hollywood’s red carpets to affluent Indians, ...
Indiatimes15h
Generic Pharmasec - Genpharmasec Share Price
Company has Koshal & Associates as its auditors. As on 30-09-2024, the company has a total of 55.37 Crore shares outstanding.Generic Pharmasec Share Price Today is Rs. 3.32 as on 02 Jan, 2025, 09:43 ...